68Ga-SATO in pediatric neuroblastoma patient; exploratory, safety, non-randomized, open label, comparative study
Latest Information Update: 09 May 2023
At a glance
- Drugs SS-0120 (Primary)
- Indications Neuroblastoma
- Focus Adverse reactions
- Acronyms GAP NBL
Most Recent Events
- 26 Sep 2022 New trial record